SMMT
Summit Therapeutics PLC
16.80$
+0.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +18,314.7% | -3.8% | +79.5% | +49.4% | -71.0% | -8.5% | -56.2% | -24.1% | +13.0% | +74.1% | +142.9% | +22.2% | +31.6% | +62.6% | +4.1% | -5.1% | -0.2% | +11.6% | +544.2% | -70.3% | +116.7% | +60.2% | |
| – | +18,287.6% | -12.2% | +63.1% | -34.2% | -69.2% | +36.0% | -44.3% | -29.7% | +59.2% | -22.7% | +348.4% | +29.7% | +40.3% | +21.9% | +20.5% | +1.5% | +3.7% | +12.0% | +642.1% | -72.0% | +125.5% | +57.9% | |
| – | +18,167.6% | -93.0% | +1,832.3% | -44.1% | -80.5% | +148.1% | -47.1% | -36.6% | +63.7% | -37.3% | +406.9% | +36.8% | +51.1% | -18.9% | +23.8% | +41.8% | -2.4% | +9.1% | +434.0% | -80.1% | +48.2% | +99.5% | |
| – | +18,167.6% | -15.4% | +59.1% | -44.1% | -80.5% | +148.1% | -47.1% | -36.6% | +63.7% | -37.3% | +406.9% | +36.8% | +51.1% | -18.9% | +23.8% | +41.8% | -2.4% | +9.1% | +434.0% | -48.1% | +123.6% | +60.7% | |
| – | – | +115.3% | +181.8% | +47.0% | +5.4% | -72.6% | -26.0% | +193.2% | 0.0% | -21.8% | +109.8% | +51.5% | +107.7% | +177.6% | -4.9% | -97.5% | +2,252.1% | +70.0% | -60.8% | -86.5% | -33.7% | – | |
| – | – | 0.0% | +665.1% | +81.7% | -15.9% | – | – | – | – | -100.0% | +416,311,200.0% | -86.5% | -80.4% | -100.0% | – | – | -750,641,125.6% | – | +0.0% | -65.9% | – | – | |
| – | – | – | – | – | – | – | – | – | – | +97.2% | +16.9% | +0.0% | +39.8% | +597.4% | -23.9% | +89.4% | +9.6% | +172.4% | +45.8% | – | – | – | |
| – | – | – | – | 0.0% | – | – | – | – | – | – | +50.7% | -5.5% | -12.2% | +322.6% | -32.2% | -51.5% | +29.3% | -0.1% | -1.6% | +2.2% | -0.6% | -0.3% | |
| – | 0.0% | +32.7% | +5,621.7% | +465.4% | -57.0% | +4.3% | -76.0% | -0.4% | -84.4% | +1,193.2% | +50.2% | -5.7% | -12.3% | +382.5% | -33.5% | -44.5% | +9.6% | -8.9% | +34.9% | – | – | – | |
| – | +9,500.0% | +611.6% | +153.9% | +141.8% | -49.2% | -33.6% | -56.6% | +4.6% | +3.0% | +73.3% | +132.0% | -42.1% | +814.4% | +21.5% | -62.0% | -39.6% | +18.0% | +31.8% | +1,864.5% | -77.4% | -62.3% | +83.2% | |
| – | +9,500.0% | +259.4% | +125.7% | +139.0% | -60.4% | -34.5% | +8.4% | +5.6% | +19.5% | +27.9% | +74.5% | -15.1% | +198.3% | +96.9% | -36.0% | -42.4% | +47.6% | +30.0% | +66.4% | -48.9% | +106.5% | +62.4% | |
| – | – | 0.0% | +9.9% | +188.8% | -48.0% | – | – | – | +63.7% | – | – | – | 0.0% | +254.0% | -100.0% | – | – | +182.3% | +2,063.1% | -87.3% | +35.3% | -16.4% | |
| – | 0.0% | +2,470.4% | +159.2% | +59.7% | -73.0% | -75.5% | +120.7% | +284.1% | +7.7% | -73.5% | +834.4% | -15.1% | +9.1% | +153.9% | -54.1% | -41.8% | +33.6% | -28.1% | -91.1% | +629.3% | +75.5% | +306.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -79.8% | – | – | |
| – | +18,540.7% | -11.9% | +71.6% | +34.8% | -77.2% | +7.3% | -56.0% | -35.1% | +19.2% | +74.4% | +148.6% | +54.1% | -114.5% | – | +299.1% | +9.5% | -4.5% | +5.8% | +67.2% | -40.5% | +405.3% | +57.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +23.3% | +33.4% | +16.3% | +31.5% | +11.5% | +25.5% | -43.0% | +365.9% | -91.1% | +29.7% | +93.1% | +49.3% | +4.1% | +6.3% | +31.7% | -61.9% | +111.8% | +32.7% | +109.6% | +220.5% | +16.0% | +4.1% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.